Apollo Global Management, Inc. APO
NYSE · XNYS · stock · Investment Advice · website · IPO 2011-03-29
Chart by TradingView
5/9
Piotroski F — financial health
—
Altman Z″ — distress risk
34.4%
Dividend payout · safe
Valuation · market cap as of 2026-06-29
Market cap$68.2B
P / E19.5×
P / S2.1×
P / B1.6×
Dividend yield1.76%
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $32.0B | $26.1B | $32.6B | $11.0B | $6.0B |
| Net income | $3.5B | $4.6B | $5.0B | -$2.0B | $1.8B |
| Operating cash flow | $7.2B | $3.3B | $6.3B | $3.8B | $1.1B |
| Total assets | $460.9B | $377.9B | $313.5B | $257.2B | $30.5B |
| Total liabilities | $418.4B | $346.9B | $288.2B | $241.8B | $18.5B |
| Shareholders' equity | $42.5B | $31.0B | $25.2B | $14.4B | $10.2B |
| Ratios | |||||
| Net margin | 10.9% | 17.5% | 15.5% | -17.9% | 30.9% |
| Return on assets | 0.8% | 1.2% | 1.6% | -0.8% | 6.0% |
| Return on equity | 8.2% | 14.8% | 20.0% | -13.7% | 18.0% |
| Debt / equity | 0.31× | 0.34× | 0.32× | 0.45× | 0.31× |
| Revenue growth | 22.7% | -20.0% | 197.6% | 84.3% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| TIGER GLOBAL MANAGEMENT LLC | 3,293,334 | $366.9M |
| SOROS FUND MANAGEMENT LLC | 131,351 | $14.6M |
| RENAISSANCE TECHNOLOGIES LLC | 94,889 | $10.6M |
| Point72 Asset Management, L.P. | 67,000 | $7.5M |
| Bridgewater Associates, LP | 4,513 | $502,838 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
IX · MUFG · MFG · NMR · UNH · CI · all Finance, Insurance & Real Estate →
Source: SEC EDGAR filings · CIK 0001858681 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.